News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Valeant Pharmaceuticals International (VRX) to Pay Anacor Pharmaceuticals, Inc. (ANAC) $100 Million in Breach of Contract Dispute



10/18/2013 10:15:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Shares of Anacor Pharmaceuticals climbed Friday after the company said an arbitrator is awarding the company $100 million in a dispute with Canadian drugmaker Valeant Pharmaceuticals. The companies said Valeant was ordered to pay $100 million in damages and will also have to pay costs and attorney's fees. Anacor said it expects the award to be confirmed by the end of the year, and after that Valeant will have up to six months to pay.

Help employers find you! Check out all the jobs and post your resume.

Read at BusinessWeek
Read at Street Insider
Read at News-Medical
Read at RTT News


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES